Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population

HIV Med. 2004 Mar;5(2):88-92. doi: 10.1111/j.1468-1293.2004.00191.x.

Abstract

Aim: Although the benefits of antiretroviral therapy (ART) have been dramatic, studies have started to report a variety of drug-related side effects and toxicities. We sought to characterize the risk factors for cardiovascular disease present in an HIV-positive population.

Methods: A total of 394 HIV-positive ambulant patients attending the Royal Free Hospital, London, were asked to complete a questionnaire. Questions focused on smoking habits and general health.

Results: In total, 38% of patients were aged >40 years, 37% had a family history of heart disease, 3% had diabetes, 14% suffered from raised blood pressure, 20% had a body mass index (BMI)>26 kg/m3, 7% had an alcohol consumption above the recommended UK limit, and 18% had total cholesterol levels >6.3 mmol/L [corrected]. The rate of smoking observed (45%) was much higher than that observed amongst the general population in the British Health Survey for England (34%). There were significant differences between those receiving and not receiving ART. Those on ART tended to be younger (P<0.0001) and less likely to smoke cigarettes (P=0.06) or have an alcohol consumption above the recommended limit (P=0.08), but were more likely to have diabetes (P=0.05). More patients receiving ART reported, and so perceived themselves to have, raised blood fats (P<0.0001). This was confirmed when considering blood lipid levels, where those on ART had significantly raised total cholesterol levels compared to those not currently receiving ART (P<0.0001).

Conclusion: We have demonstrated an excess of cardiovascular risk factors in this cohort. These issues must be addressed if we wish to maintain the benefit of treating HIV infection.

MeSH terms

  • Adult
  • Alcohol Drinking / adverse effects
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cardiovascular Diseases / chemically induced*
  • Cross-Sectional Studies
  • England
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Risk Factors
  • Smoking / adverse effects
  • Surveys and Questionnaires
  • Treatment Outcome